Apimeds Pharmaceuticals US, Inc.
$7.25
▲ +2.33
(+47.36%)
Volume: 36,893,731
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
75
- 21d momentum +57.6%
- RSI 78 overbought
🎯
Pullback
25
- Near upper Bollinger band
- +166.5% vs 20MA
💎
Value
58
- -88% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)77.5
MACD+0.569
MA trendMixed
ATR16.05%
21d mom.+57.6%
63d mom.-19.4%
vs 20MA+166.5%
RVOL(20)8.12×
52w low · 2
52w high · 60
-87.9% from 52-week high
20d support 2
· resistance 9
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$7M
PER—
PBR0.07
PSR—
EPS$-38.55
ROE-54.6%
ROA-45.6%
Dividend yield0.00%
Debt/Equity0.08
EV/EBITDA-0.59
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| +309.60% | +57.61% | -19.44% | -47.08% | -62.53% | -56.46% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum +199.59%, daily vol 24.68%. Apimeds Pharmaceuticals US, Inc. sits in a bullish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.